Skip to the main content

Review article

https://doi.org/10.37797/ig.40.4.5

Pulmonary Embolism in Pneumonia

Bea Hohšteter ; School of Medicine, University of Zagreb, Croatia
Lidija Ljubičić orcid id orcid.org/0000-0003-2493-4847 ; Clinic for Pulmonary Diseases Jordanovac, Clinical Hospital Center Zagreb, Croatia
Gordana Pavliša ; School of Medicine, University of Zagreb; Clinic for Pulmonary Diseases Jordanovac, Clinical Hospital Center Zagreb, Croatia


Full text: croatian pdf 193 Kb

page 148-153

downloads: 880

cite

Full text: english pdf 193 Kb

page 148-153

downloads: 283

cite


Abstract

Pneumonia and pulmonary embolism (PE) share common risk factors, radiological findings and one disease may induce the development of another. The clinical characteristics of pneumonia can completely mask the concomitant PE, which, along with the increase in D-dimer due to inflammatory events, significantly complicates the screening of patients who need imaging diagnostic methods. A specific feature (including the exact D-dimer cut-off value), which would clearly indicate concomitant PE in pneumonia has not yet been established. However, older age, comorbidities, chest pain, dyspnea and syncope are more common in pneumonia with coexisting PE than in pneumonia alone. In new coronavirus associated pneumonia (COVID-19), PE is far more frequent than in pneumonia caused by other microorganisms. PE in COVID-19 pneumonia is associated with risk factors such as male sex, higher levels of C-reactive protein and delayed hospitalization. Anticoagulant-prophylaxis reduces the incidence of PE in COVID-19 pneumonia.

Keywords

pulmonary embolism; pneumonia; D-dimers; COVID-19; anticoagulants

Hrčak ID:

254023

URI

https://hrcak.srce.hr/254023

Publication date:

18.3.2021.

Article data in other languages: croatian

Visits: 2.558 *